Canonical Wnt Signalling in Xenopus Simon Wilfred Fellgett

Total Page:16

File Type:pdf, Size:1020Kb

Canonical Wnt Signalling in Xenopus Simon Wilfred Fellgett The effects of Sulf1 on canonical and non- canonical Wnt signalling in Xenopus Simon Wilfred Fellgett Thesis submitted for the degree of Doctor of Philosophy The University of York Department of Biology September 2013 Abstract Heparan sulphate proteoglycans are large macromolecules expressed on the cell surface. They are an important part of the extracellular matrix and regulate multiple cell signalling pathways. Sulf1 is an extracellular sulfatase that specifically removes 6-O linked sulphate groups from heparan sulphate chains. The activity of Sulf1 alters the ability of heparan sulphate chains to regulate FGF, BMP, hedgehog and Wnt signalling pathways. The original work that identified Sulf1 (Dhoot et al., 2001), demonstrated that Sulf1 enhanced the ability of Wnt1 to activate canonical Wnt signalling. This thesis uses Xenopus to investigate the effects of Sulf1 on canonical and non-canonical Wnt signalling in the early embryo. Sulf1 has ligand specific effects on different Wnt ligands, inhibiting the ability of Wnt8a, but not Wnt3a, to activate canonical Wnt signalling. In addition Sulf1 potentiates the ability of Wnt4 to activate non- canonical Wnt signalling and Wnt11b to activate both canonical and non- canonical Wnt signalling. Confocal analysis of animal caps expressing fluorescently tagged Wnt ligands shows that Sulf1 can enhance the range of diffusion of both Wnt8a and Wnt11b. The ability of Sulf1 to regulate Wnt ligand diffusion may explain some of the differential effects of Sulf1 on Wnt signalling. The results described in this thesis are discussed in terms of Sulf1 regulating Wnt morphogen gradients during development. The differential effects of Sulf1 on canonical and non-canonical Wnt signalling described here requires more than the existing ‘catch and present’ model (Ai et al., 2003). A new model is presented here. 2 Table of contents Abstract ................................................................................................................. 2 Table of contents ................................................................................................... 3 Acknowledgments ............................................................................................... 15 Author’s declaration ............................................................................................. 17 1.0 Introduction.................................................................................................. 18 1.1.0 Determination of cell fate by morphogens ................................................... 19 1.2.0 Identification the Wg pathway in Drosophila ................................................ 20 1.2.1 The Wg signalling pathway ......................................................................... 22 1.2.2 The Drosophila planar cell polarity pathway ................................................ 26 1.3.0 The vertebrate Wnts ................................................................................... 28 1.3.1 Wnt/Wg synthesis and secretion ................................................................. 30 1.3.2 The canonical Wnt receptors ...................................................................... 31 1.3.3 The canonical Wnt signalling pathway ........................................................ 33 In the absence of Wnt ...................................................................................... 33 In the presence of Wnt ..................................................................................... 34 1.4.0 Establishing the organiser domain .............................................................. 35 1.4.1 Cell behaviour during gastrulation ............................................................... 37 1.4.2 Regulating vertebrate gastrulation .............................................................. 38 1.5.0 The role of non-canonical Wnt signalling during gastrulation ....................... 39 1.5.1 The PCP pathway regulates cell behaviour during gastrulation ................... 40 1.5.2 The Wnt/calcium pathway ........................................................................... 42 1.6.0 Cross regulation of the canonical and non-canonical Wnt signalling pathways ............................................................................................................................ 44 1.6.1 Activating the canonical and non-canonical Wnt signalling cascades .......... 46 1.6.2 Intracellular trafficking of Wnt receptor complexes ...................................... 48 1.7.0 Heparan sulphate proteoglycans ................................................................ 49 1.7.1 Membrane bound HSPGs ........................................................................... 50 Syndecans ....................................................................................................... 50 3 Glypicans ......................................................................................................... 50 Perlecans ......................................................................................................... 51 1.7.2 HSPG synthesis .......................................................................................... 52 Chain initiation.................................................................................................. 52 Chain polymerisation ........................................................................................ 53 Chain modifications .......................................................................................... 53 1.7.3 HSPGs regulate a variety of developmental signalling pathways ................ 54 1.7.4 HSPGs require sulphate modifications to activate cell signalling ................. 56 1.8.0 Post synthetic modification of HSPGs by the extracellular sulfatases Sulf1 and 2 ................................................................................................................... 58 Sulf1 ................................................................................................................. 58 Sulf 2 ................................................................................................................ 59 1.8.1 Sulf1 has a regulatory function during development .................................... 60 1.8.2 Sulf1 modulates multiple cell signalling pathways ....................................... 61 FGF signalling .................................................................................................. 61 BMP signalling ................................................................................................. 62 Wnt signalling ................................................................................................... 62 1.9.0 Aims of this study ........................................................................................ 65 2.0 Materials and Methods ........................................................................... 66 2.1 Materials and solutions ............................................................................ 67 2.1.1 Summary of materials ................................................................................. 67 2.1.2 Summary of solutions ................................................................................. 70 2.1.3 Summary of antibodies ............................................................................... 74 In situ hybridisation .......................................................................................... 74 Western blot ..................................................................................................... 74 2.2 Embryological methods ........................................................................... 74 2.2.1 Xenopus laevis in vitro fertilisation and culture ............................................ 74 2.2.2 Xenopus tropicalis in vitro fertilisation and culture ....................................... 75 2.2.3 Microinjection .............................................................................................. 75 2.2.4 Animal cap assays ...................................................................................... 76 Convergent extension assays .......................................................................... 76 4 Western blot ..................................................................................................... 76 Confocal microscopy ........................................................................................ 76 2.2.5 In situ hybridisation ..................................................................................... 77 2.2.6 Photography ............................................................................................... 78 2.3 Molecular biology methods ...................................................................... 78 2.3.1 Transformation ............................................................................................ 78 2.3.2 Colony PCR ................................................................................................ 78 2.3.3 Agarose gel electrophoresis ........................................................................ 79 2.3.4 DNA minipreps ............................................................................................ 79 2.3.5 Quantification of DNA and RNA .................................................................. 79 2.3.6 Sequencing ................................................................................................. 80 2.3.7 Linearizing plasmid DNA
Recommended publications
  • Role of Sulfs in Colorectal Cancer Cells Original Article Enhanced
    Author Manuscript Published OnlineFirst on December 4, 2014; DOI: 10.1158/1541-7786.MCR-14-0372 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Running Title: Role of SULFs in colorectal cancer cells Original Article Enhanced Tumorigenic Potential of Colorectal Cancer Cells by Extracellular Sulfatases Carolina M Vicente1, Marcelo A Lima1,2, Edwin A Yates2,1, Helena B Nader1, Leny Toma1* 1Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, UNIFESP, Brazil 2Institute of Integrative Biology, Department of Biochemistry, University of Liverpool, Liverpool, UK *Corresponding author: Leny Toma, Disciplina de Biologia Molecular, Universidade Federal de São Paulo, UNIFESP, Rua Três de Maio, 100 – 4º andar, Vila Clementino, CEP 04044-020, São Paulo, SP, Brazil. E-mail: [email protected], [email protected], Tel (+55) (11) 55793175; FAX (+55) (11) 55736407. Disclosure of Potential Conflicts of Interest No potential conflicts of interest were disclosed by the authors. Downloaded from mcr.aacrjournals.org on September 24, 2021. © 2014 American Association for Cancer Research. Author Manuscript Published OnlineFirst on December 4, 2014; DOI: 10.1158/1541-7786.MCR-14-0372 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Heparan sulfate endosulfatase-1 and -2 (SULF1 and SULF2) are two important extracellular 6-O-endosulfatases that remove 6-O sulfate groups of N-glucosamine along heparan sulfate (HS) proteoglycan chains often found in the extracellular matrix (ECM). The HS sulfation pattern influences signaling events at the cell surface, which are critical for interactions with growth factors and their receptors.
    [Show full text]
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Gene Section Review SULF1 (sulfatase 1) Jérôme Moreaux INSERM U1040, institut de recherche en biotherapie, CHRU Saint Eloi, 80 Av Augustain Fliche, 34295 Montpellier CEDEX 5, France (JM) Published in Atlas Database: March 2012 Online updated version : http://AtlasGeneticsOncology.org/Genes/SULF1ID44378ch8q13.html DOI: 10.4267/2042/47490 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2012 Atlas of Genetics and Cytogenetics in Oncology and Haematology - Homo sapiens sulfatase 1 (SULF1), transcript variant Identity 3, mRNA, 5710 bp Other names: HSULF-1, SULF-1 Accession: NM_015170.2 GI: 189571635 HGNC (Hugo): SULF1 - Homo sapiens sulfatase 1 (SULF1), transcript variant 4, mRNA, 5548 bp Location: 8q13.2 Accession: NM_001128204.1 GI: 189571637 DNA/RNA Protein Note Note The sulfation pattern of heparan sulfate chains Sulfs are sulfatases that edit the sulfation status of influences signaling events mediated by heparan sulfate heparan sulfate proteoglycans on the outside of cells proteoglycans located on cell surface. SULF1 is an and regulate a number of critical signaling pathways. endosulfatase able to cleave specific 6-O sulfate groups The Sulfs are dysregulated in many cancers. within the heparan chains. The Sulfs are synthesized as pre-proproteins. This action can modulate signaling processes, The signal sequence is removed and the pro-protein is modulating the effects of heparan sulfate by altering cleaved by a furin-type proteinase. binding sites for signaling molecules. Sulfs mature proteins are secreted as well as retained Description on the cell surface.
    [Show full text]
  • Simulation of Morphogen and Tissue Dynamics
    Simulation of morphogen and tissue dynamics M. D. Peters, L. D. Wittwer, A. Stopka, D. Barac, C. Lang, D. Iber Abstract Morphogenesis, the process by which an adult organism emerges from a single cell, has fascinated humans for a long time. Modelling this process can provide novel insights into development and the principles that orchestrate the developmental processes. This chapter focusses on the mathematical description and numerical simulation of developmental processes. In particular, we discuss the mathematical representation of morphogen and tissue dynamics on static and grow- ing domains, as well as the corresponding tissue mechanics. In addition, we give an overview of numerical methods that are routinely used to solve the resulting systems of partial differential equations. These include the finite element method and the Lattice Boltzmann method for the discretisation as well as the arbitrary Lagrangian- Eulerian method and the Diffuse-Domain method to numerically treat deforming domains. 1 Introduction During morphogenesis, the coordination of the processes that control size, shape, and pattern is essential to achieve stereotypic outcomes and comprehensive func- tionality of the developing organism. There are two main components contributing to the precisely orchestrated process of morphogenesis: morphogen dynamics and tissue dynamics. While signalling networks control cellular behaviour, such as pro- liferation and differentiation, tissue dynamics in turn modulate diffusion, advection and dilution, and affect the position of morphogen sources and sinks. Due to this interconnection, the regulation of those processes is very complex. Although a large arXiv:1806.04138v1 [q-bio.TO] 11 Jun 2018 amount of experimental data is available today, many of the underlying regulatory mechanisms are still unknown.
    [Show full text]
  • Sulf1 Influences the Shh Morphogen Gradient During the Dorsal Ventral Patterning of the Neural Tube in Xenopus Tropicalis
    Ramsbottom SA, Maguire RJ, Fellgett SW, Pownall ME. Sulf1 influences the Shh morphogen gradient during the dorsal ventral patterning of the neural tube in Xenopus tropicalis. Developmental Biology 2014, 39(391), 207-218. Copyright: © 2014 Elsevier Inc. All rights reserved. Published under an Elsevier user license DOI link to article: http://dx.doi.org/10.1016/j.ydbio.2014.04.010 Date deposited: 22/09/2016 This work is licensed under a Creative Commons Attribution 4.0 International License Newcastle University ePrints - eprint.ncl.ac.uk Developmental Biology 391 (2014) 207–218 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/locate/developmentalbiology Sulf1 influences the Shh morphogen gradient during the dorsal ventral patterning of the neural tube in Xenopus tropicalis Simon A. Ramsbottom, Richard J. Maguire, Simon W. Fellgett, Mary Elizabeth Pownall n Biology Department, University of York, York YO10 5YW, United Kingdom article info abstract Article history: Genetic studies have established that heparan sulphate proteoglycans (HSPGs) are required for signalling Received 1 November 2013 by key developmental regulators, including Hedgehog, Wnt/Wg, FGF, and BMP/Dpp. Post-synthetic Received in revised form remodelling of heparan sulphate (HS) by Sulf1 has been shown to modulate these same signalling 11 April 2014 pathways. Sulf1 codes for an N-acetylglucosamine 6-O-endosulfatase, an enzyme that specifically Accepted 15 April 2014 removes the 6-O sulphate group from glucosamine in highly sulfated regions of HS chains. One striking Available online 24 April 2014 aspect of Sulf1 expression in all vertebrates is its co-localisation with that of Sonic hedgehog in the floor Keywords: plate of the neural tube.
    [Show full text]
  • Heparan Sulfate Proteoglycan
    Cellular Signalling 54 (2019) 115–121 Contents lists available at ScienceDirect Cellular Signalling journal homepage: www.elsevier.com/locate/cellsig Heparan sulfate proteoglycan – A common receptor for diverse cytokines T ⁎ Meng Xiea, Jin-ping Lib, a Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden b Department of Medical Biochemistry and Microbiology, SciLifeLab Uppsala, The Biomedical Center, University of Uppsala, Uppsala, Sweden ARTICLE INFO ABSTRACT Keywords: Heparan sulfate proteoglycans (HSPG) are macromolecular glyco-conjugates expressed ubiquitously on the cell Heparan sulfate proteoglycan surface and in the extracellular matrix where they interact with a wide range of ligands to regulate many aspects Cytokines of cellular function. The capacity of the side glycosaminoglycan chain heparan sulfate (HS) being able to interact Cellular signaling with diverse protein ligands relies on its complex structure that is generated by a controlled biosynthesis process, Heparin involving the actions of glycosyl-transferases, sulfotransferases and the glucuronyl C5-epimerase. It is believed that activities of the modification enzymes control the HS structures that are designed to serve the biological functions in a given cell or biological status. In this review, we briefly discuss recent understandings on the roles of HSPG in cytokine stimulated cellular signaling, focusing on FGF, TGF-β, Wnt, Hh, HGF and VEGF. 1. Introduction 2. Biosynthesis of HS Heparan sulfate proteoglycans (HSPGs) are macromolecules, typi- The capacity of HS to interact with a wide diversity of cytokines is cally composed of a core protein, to which several heparan sulfate (HS) attributed to its complex structures that are formed by a controlled glycosaminoglycan chains are covalently attached [1,2].
    [Show full text]
  • Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
    Molecules 2015, 20, 6342-6388; doi:10.3390/molecules20046342 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use Paola Chiodelli, Antonella Bugatti, Chiara Urbinati and Marco Rusnati * Section of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy; E-Mails: [email protected] (P.C.); [email protected] (A.B.); [email protected] (C.U.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +39-030-371-7315; Fax: +39-030-371-7747. Academic Editor: Els Van Damme Received: 26 February 2015 / Accepted: 1 April 2015 / Published: 10 April 2015 Abstract: Angiogenesis, the process of formation of new blood vessel from pre-existing ones, is involved in various intertwined pathological processes including virus infection, inflammation and oncogenesis, making it a promising target for the development of novel strategies for various interventions. To induce angiogenesis, angiogenic growth factors (AGFs) must interact with pro-angiogenic receptors to induce proliferation, protease production and migration of endothelial cells (ECs). The action of AGFs is counteracted by antiangiogenic modulators whose main mechanism of action is to bind (thus sequestering or masking) AGFs or their receptors. Many sugars, either free or associated to proteins, are involved in these interactions, thus exerting a tight regulation of the neovascularization process. Heparin and heparan sulfate proteoglycans undoubtedly play a pivotal role in this context since they bind to almost all the known AGFs, to several pro-angiogenic receptors and even to angiogenic inhibitors, originating an intricate network of interaction, the so called “angiogenesis glycomic interactome”.
    [Show full text]
  • Medea Sumoylation Restricts the Signaling Range of the Dpp Morphogen in the Drosophila Embryo
    Downloaded from genesdev.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo Wayne O. Miles,1 Ellis Jaffray,2 Susan G. Campbell,1 Shugaku Takeda,1,4 Laura J. Bayston,1 Sanjay P. Basu,1 Mingfa Li,3,5 Laurel A. Raftery,3 Mark P. Ashe,1 Ronald T. Hay,2 and Hilary L. Ashe1,6 1Faculty of Life Sciences, The University of Manchester, Manchester, M13 9PT, United Kingdom; 2School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; 3Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02109, USA Morphogens are secreted signaling molecules that form concentration gradients and control cell fate in developing tissues. During development, it is essential that morphogen range is strictly regulated in order for correct cell type specification to occur. One of the best characterized morphogens is Drosophila Decapentaplegic (Dpp), a BMP signaling molecule that patterns the dorsal ectoderm of the embryo by activating the Mad and Medea (Med) transcription factors. We demonstrate that there is a spatial and temporal expansion of the expression patterns of Dpp target genes in SUMO pathway mutant embryos. We identify Med as the primary SUMOylation target in the Dpp pathway, and show that failure to SUMOylate Med leads to the increased Dpp signaling range observed in the SUMO pathway mutant embryos. Med is SUMO modified in the nucleus, and we provide evidence that SUMOylation triggers Med nuclear export. Hence, Med SUMOylation provides a mechanism by which nuclei can continue to monitor the presence of extracellular Dpp signal to activate target gene expression for an appropriate duration.
    [Show full text]
  • WT1-Dependent Sulfatase Expression Maintains the Normal Glomerular Filtration Barrier
    BASIC RESEARCH www.jasn.org WT1-Dependent Sulfatase Expression Maintains the Normal Glomerular Filtration Barrier Vale´rie A. Schumacher,*† Ursula Schlo¨tzer-Schrehardt,‡ S. Ananth Karumanchi,§ ʈ ʈ Xiaofeng Shi, Joseph Zaia, Stefanie Jeruschke,† Dongsheng Zhang,§ Hermann Pavenstädt,¶ Astrid Drenckhan,† Kerstin Amann,** Carrie Ng,* Sunny Hartwig,* Kar-Hui Ng,* Jacqueline Ho,* Jordan A. Kreidberg,* Mary Taglienti,* Brigitte Royer-Pokora,† and Xingbin Ai†† *Department of Medicine, Children’s Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; †Institute of Human Genetics, University of Du¨sseldorf, Du¨sseldorf, Germany; ‡Department of Ophthalmology and **Institute for Pathology, University of Erlangen-Nu¨rnberg, Nu¨rnberg, Germany; §Beth Israel ʈ Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Biochemistry and ††The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts; and ¶Department of Medicine D, University of Mu¨nster, Mu¨nster, Germany ABSTRACT Paracrine signaling between podocytes and glomerular endothelial cells through vascular endothelial growth factor A (VEGFA) maintains a functional glomerular filtration barrier. Heparan sulfate proteogly- cans (HSPGs), located on the cell surface or in the extracellular matrix, bind signaling molecules such as VEGFA and affect their local concentrations, but whether modulation of these moieties promotes normal crosstalk between podocytes and endothelial cells is unknown. Here, we found that the transcription factor Wilms’ Tumor 1 (WT1) modulates VEGFA and FGF2 signaling by increasing the expression of the 6-O-endosulfatases Sulf1 and Sulf2, which remodel the heparan sulfate 6-O-sulfation pattern in the extracellular matrix. Mice deficient in both Sulf1 and Sulf2 developed age-dependent proteinuria as a result of ultrastructural abnormalities in podocytes and endothelial cells, a phenotype similar to that ϩ/Ϫ observed in children with WT1 mutations and in Wt1 mice.
    [Show full text]
  • Getting the Measure of Positional Information Johannes Jaeger, Alfonso Martinez-Arias
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Primer Getting the Measure of Positional Information Johannes Jaeger, Alfonso Martinez-Arias Of Fruit Flies and French Flags detection of concentration thresholds by cells in the target Understanding the mechanisms that underlie pattern tissue [9]. Early efforts to model the system indicated formation is one of the major challenges of developmental that target gene auto-activation [11], or more complex biology. The complexity and beauty of the patterns on interactions among downstream factors [12,13], would be butterfly wings, fish scales, or bird feathers are not only necessary to achieve the required robustness. However, remarkable products of developmental processes but these studies were hampered by the absence of reliable puzzles that tease our intellects. If we are to understand experimental evidence on the variability of gene expression these beautiful products of cellular activity, we need to against which the models could be tested. first investigate simpler patterns, which are more tractable Quantification at Last! experimentally. A good example is the subdivision of an embryo along its main axis, which can be represented as a Developmental biology is changing. Qualitative, descriptive polarized subdivision of a cellular field. Over 40 years ago, approaches are beginning to yield to quantitative, analytical Lewis Wolpert offered a conceptual solution to this problem ones, through the development of optical and analytical in the form of the French Flag model [1]. The central element techniques. These approaches allow us to state more precise of the proposal is that spatial gradients of substances called hypotheses (formulated as predictive models), which morphogens are the cause of such subdivision (Figure 1, left can be tested more rigorously.
    [Show full text]
  • Differential Expression Profile Prioritization of Positional Candidate Glaucoma Genes the GLC1C Locus
    LABORATORY SCIENCES Differential Expression Profile Prioritization of Positional Candidate Glaucoma Genes The GLC1C Locus Frank W. Rozsa, PhD; Kathleen M. Scott, BS; Hemant Pawar, PhD; John R. Samples, MD; Mary K. Wirtz, PhD; Julia E. Richards, PhD Objectives: To develop and apply a model for priori- est because of moderate expression and changes in tization of candidate glaucoma genes. expression. Transcription factor ZBTB38 emerges as an interesting candidate gene because of the overall expres- Methods: This Affymetrix GeneChip (Affymetrix, Santa sion level, differential expression, and function. Clara, Calif) study of gene expression in primary cul- ture human trabecular meshwork cells uses a positional Conclusions: Only1geneintheGLC1C interval fits our differential expression profile model for prioritization of model for differential expression under multiple glau- candidate genes within the GLC1C genetic inclusion in- coma risk conditions. The use of multiple prioritization terval. models resulted in filtering 7 candidate genes of higher interest out of the 41 known genes in the region. Results: Sixteen genes were expressed under all condi- tions within the GLC1C interval. TMEM22 was the only Clinical Relevance: This study identified a small sub- gene within the interval with differential expression in set of genes that are most likely to harbor mutations that the same direction under both conditions tested. Two cause glaucoma linked to GLC1C. genes, ATP1B3 and COPB2, are of interest in the con- text of a protein-misfolding model for candidate selec- tion. SLC25A36, PCCB, and FNDC6 are of lesser inter- Arch Ophthalmol. 2007;125:117-127 IGH PREVALENCE AND PO- identification of additional GLC1C fami- tential for severe out- lies7,18-20 who provide optimal samples for come combine to make screening candidate genes for muta- adult-onset primary tions.7,18,20 The existence of 2 distinct open-angle glaucoma GLC1C haplotypes suggests that muta- (POAG) a significant public health prob- tions will not be limited to rare descen- H1 lem.
    [Show full text]
  • Evaluation of Small Molecules for Neuroectoderm Differentiation & Patterning Using Factorial Experimental Design
    Evaluation of Small Molecules for Neuroectoderm differentiation & patterning using Factorial Experimental Design Master Thesis in Applied Physics For the degree of Master of Science in Biotechnology DIMITRIOS VOULGARIS Department of Physics, Division of Biological Physics CHALMERS UNIVERSITY OF TECHNOLOGY Göteborg, Sweden 2016 Master thesis in Applied Physics Evaluation of Small Molecules for Neuroectoderm differentiation and patterning using Factorial Experimental Design Dimitrios Voulgaris Department of Physics Division of Biological Physics CHALMERS UNIVERSITY OF TECHNOLOGY Göteborg, Sweden 2016 Evaluation of Small Molecules for Neuroectoderm differentiation and patterning using Factorial Experimental Design DIMITRIOS VOULGARIS © DIMITRIOS VOULGARIS, 2016 Supervisor: Anders Lundin, Industrial PhD candidate, Astra Zeneca and Karolinska Institutet Examiner: Julie Gold, Associate Professor, Division of Biological Physics, Department of Physics, Chalmers University of Technology Master thesis for the degree of M.Sc. in Biotechnology Division of Biological Physics Department of Physics Chalmers University of Technology SE-142 96 Göteborg Sweden Telephone +46 (0)31-722 1000 Cover: hiPSCs differentiated for 4 days on LN-521 in neural induction N2B27 medium stained with DAPI (blue) and the intermediate filament Nestin (green). Printed by Chalmers Reproservice Göteborg, Sweden 2016 Evaluation of Small Molecules for Neuroectoderm differentiation and patterning using Factorial Experimental Design DIMITRIOS VOULGARIS Department of Physics Chalmers University of Technology Evaluation of Small Molecules for Neuroectoderm differentiation and patterning using Factorial Experimental Design DIMITRIOS VOULGARIS Department of Physics Chalmers University of Technology ABSTRACT Screening for therapeutic compounds and treatments for diseases of the Brain does not only encompass the successful generation of iPS-derived homogenous neural stem cell populations but also the capacity of the differentiation protocol to derive on-demand region-specific cells.
    [Show full text]
  • Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer
    REVIEW published: 25 June 2021 doi: 10.3389/fonc.2021.695858 Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer Simone Furini and Chiara Falciani* Department of Medical Biotechnologies, University of Siena, Siena, Italy Pancreatic cancer is a lethal condition with poor outcomes and an increasing incidence. The unfavourable prognosis is due to the lack of early symptoms and consequent late diagnosis. An effective method for the early diagnosis of pancreatic cancer is therefore sought by many researchers in the field. Heparan sulfated proteoglycan-related genes are often expressed differently in tumors than in normal tissues. Alteration of the tumor microenvironment is correlated with the ability of heparan sulfated proteoglycans to bind cytokines and growth factors and eventually to influence tumor progression. Here we discuss the importance of glypicans, syndecans, perlecan and extracellular matrix modifying enzymes, such as heparanases and sulfatases, as potential diagnostics in Edited by: pancreatic cancer. We also ran an analysis on a multidimensional cancer genomics Manuela Viola, database for heparan sulfated proteoglycan-related genes, and report altered expression University of Insubria, Italy Reviewed by: of some of them. Sherif Ibrahim, Keywords: heparan sulfated proteoglycans, pancreatic cancer, prognosis, cancer genomics, screening, Cairo University, Egypt precision medicine Valeria De Pasquale, University of Naples Federico II, Italy *Correspondence: Chiara Falciani INTRODUCTION [email protected] Pancreatic cancer is a lethal condition with poor outcomes and an increasing incidence. It has a 5‐ Specialty section: year survival of 9% (1), the poor prognosis being due to absence of early symptoms and consequent This article was submitted to late diagnosis.
    [Show full text]